1. Home
  2. ACHV vs NHS Comparison

ACHV vs NHS Comparison

Compare ACHV & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.22

Market Cap

231.0M

Sector

Health Care

ML Signal

HOLD

Logo Neuberger Berman High Yield Strategies Fund

NHS

Neuberger Berman High Yield Strategies Fund

HOLD

Current Price

$7.56

Market Cap

230.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
NHS
Founded
N/A
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
231.0M
230.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACHV
NHS
Price
$4.22
$7.56
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$15.50
N/A
AVG Volume (30 Days)
828.7K
111.8K
Earning Date
03-10-2026
01-01-0001
Dividend Yield
N/A
13.44%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.84
$6.95
52 Week High
$6.03
$9.17

Technical Indicators

Market Signals
Indicator
ACHV
NHS
Relative Strength Index (RSI) 34.31 65.14
Support Level $4.05 $7.23
Resistance Level $4.49 $7.64
Average True Range (ATR) 0.34 0.06
MACD -0.18 0.02
Stochastic Oscillator 5.82 85.37

Price Performance

Historical Comparison
ACHV
NHS

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

Share on Social Networks: